Investing.com - Bristol-Myers Squibb reported third quarter earnings that beat analyst's expectations on Thursday and revenue that fell short of forecasts.
The firm reported earnings per share of $1.09 on revenue of $5.69B. Analysts polled by Investing.com forecast EPS of $0.9 on revenue of $5.7B. That compared to EPS of $0.75 on revenue of $5.25B in the same period a year earlier. The company had reported EPS of $1.01 on revenue of $5.7B in the previous quarter.
For the year, Bristol-Myers Squibb shares are down 2.87%, under-performing the S&P 500 which is down 1.03% year to date.
Bristol-Myers Squibb follows other major Healthcare sector earnings this month
On Tuesday, October 16, 2018, J&J (NYSE:JNJ) reported third quarter EPS of $2.05 on revenue of $20.35B, compared to forecasts of EPS of $2.03 on revenue of $20.04B.
Novartis ADR earnings beat analyst's expectations on Thursday, October 18, 2018, with third quarter EPS of $1.32 on revenue of $12.78B. Investing.com analysts expected EPS of $1.31 on revenue of $12.98B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar